Antifungal potential of sideroxylon obtusifolium and syzygium cumini and their mode of action against Candida albicans by Pereira, Jozinete Vieira et al.
UNIVERSIDADE ESTADUAL DE CAMPINAS
SISTEMA DE BIBLIOTECAS DA UNICAMP
REPOSITÓRIO DA PRODUÇÃO CIENTIFICA E INTELECTUAL DA UNICAMP
Versão do arquivo anexado / Version of attached file:
Versão do Editor / Published Version
Mais informações no site da editora / Further information on publisher's website:
http://www.tandfonline.com/doi/full/10.3109/13880209.2016.1155629
DOI: 10.3109/13880209.2016.1155629
Direitos autorais / Publisher's copyright statement:
©2016 by Taylor & Francis. All rights reserved.
DIRETORIA DE TRATAMENTO DA INFORMAÇÃO
Cidade Universitária Zeferino Vaz Barão Geraldo
CEP 13083-970 – Campinas SP
Fone: (19) 3521-6493
http://www.repositorio.unicamp.br
RESEARCH ARTICLE
Antifungal potential of Sideroxylon obtusifolium and Syzygium cumini and their
mode of action against Candida albicans
Jozinete Vieira Pereiraa*, Irlan Almeida Freiresb*, Aline Rogeria Castilhob, Marcos Guilherme da Cunhab,
Harley da Silva Alvesc and Pedro Luiz Rosalenb
aDepartment of Dentistry, State University of Paraiba, Campina Grande, PB, Brazil; bDivision of Pharmacology, Anesthesiology and Therapeutics,
Department of Physiological Sciences, Piracicaba Dental School, University of Campinas, Piracicaba, SP, Brazil; cDepartment of Pharmacy, State
University of Paraiba, Campina Grande, PB, Brazil
ABSTRACT
Context The emergence of resistant pathogens and toxicity of antifungals have encouraged an active
search for novel candidates to manage Candida biofilms.
Objective In this study, the little known species Sideroxylon obtusifolium T.D. Penn (Sapotacea) and
Syzygium cumini (L.) Skeels (Myrtaceae), from the Caatinga biome in Brazil were chemically characterized
and explored for their antifungal potential against C. albicans.
Materials and methods We determined the effects of hydroalcoholic extracts/fractions upon fungal
growth (minimum inhibitory and fungicidal concentrations, MIC/MFC), biofilm morphology (scanning elec-
tron microscopy) and viability (confocal laser scanning microscopy), proposed their mode of action (sorbitol
and ergosterol assays), and finally investigated their effects against macrophage and keratinocyte cells in a
cell-based assay. Data were analysed using one-way analysis of variance with Tukey-Kramer post-test
(a¼ 0.05).
Results The n-butanol (Nb) fraction from S. obtusifolium and S. cumini extract (Sc) showed flavonoids
(39.11 6 6.62 mg/g) and saponins (820.35 6 225.38 mg/g), respectively, in their chemical composition and
demonstrated antifungal activity, with MICs of 62.5 and 125 lg/mL, respectively. Nb and Sc may complex
with ergosterol as there was a 4–16-fold increase in MICs in the presence of exogenous ergosterol, leading
to disrupted permeability of cell membrane. Deleterious effects were observed on morphology and viability
of treated biofilms from concentrations as low as their MICs and higher. Sc was not toxic to macrophages
and keratinocytes at these concentrations (p> 0.05), unlike Nb.
Conclusions Nb and Sc demonstrated considerable antifungal activity and should be further investigated
as potential alternative candidates to treat Candida biofilms.
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Introduction
Oral candidiasis is a common superficial and opportunistic infec-
tion caused by Candida spp., mainly C. albicans, when the host
immunity becomes compromised (Dangi et al. 2010). It is consid-
ered a global health issue affecting a wide portion of individuals
in the population, such as newborns (Ali et al. 2012), oral cancer
patients (Alnuaimi et al. 2015), denture wearers (Dar-Odeh &
Shehabi 2003), among others, presenting different clinical features.
Recently, oral candidiasis has also been reported to be a risk fac-
tor for disseminated bacterial infections, which constitute a critical
and life-threatening trait, particularly in immunocompromised
individuals (Kong et al. 2015).
There are still a limited number of antifungal classes commer-
cially available, many of which have the same mechanism of
action, as a result of the few targets so far known in the fungal
cell (Pierce et al. 2013). Not surprisingly, this non-diverse arsenal
is sometimes ineffective upon microbial resistance (Ramage et al.
2012) leading to either persistent or recurrent fungal infections in
the clinical setting. In addition, some of synthetic antifungals are
potentially toxic for the host cells due to the similarity in both
eukaryotic fungal and human cell components, such as sterols
(Berman & Sudbery 2002). Biochemical engineering has been
used to modify standard antifungals or even develop novel low-
toxicity drugs (Boros-Majewska et al. 2014; Peng et al. 2015), but
most drugs have not been tested in humans. Taken together, all
these aspects have encouraged an active search for novel candi-
dates to manage oral candidiasis in susceptible patients.
With this purpose, naturally-occurring agents are considered a
promising source of bioactive molecules with antifungal properties
(Arif et al. 2009; Negri et al. 2014). Over the last century, research
on medicinal plant species has assessed their viability, sustainabil-
ity and affordability to be used as natural drugs (Iwu 2000; Negri
et al. 2014) or to prototype the development of synthetic com-
pounds. Previous studies have suggested that the little known spe-
cies Sideroxylon obtusifolium T.D. Penn (Sapotacea) (Albuquerque
et al. 2011), native to northeastern Brazil, and Syzygium cumini
(L.) Skeels (Myrtaceae) (Oliveira et al. 2007), common in tropical
Asia, could be promising antifungal agents.
S. obtusifolium, known as ‘quixabeira’, ‘quixaba’ or ‘rompe-
gib~ao’, is a medicinal plant species native to the Brazilian
Caatinga, which is a unique biome that has aroused attention for
its exuberant and unexplored biodiversity. It is threatened with
extinction mainly by the extraction of its bark in popular
CONTACT Pedro Luiz Rosalen rosalen@fop.unicamp.br Division of Pharmacology, Anesthesiology and Therapeutics, Department of Physiological Sciences,
Piracicaba Dental School, University of Campinas, Piracicaba, SP, Brazil
*These authors contributed equally to this work.
 2016 Informa UK Limited, trading as Taylor & Francis Group
PHARMACEUTICAL BIOLOGY, 2016
VOL. 54, NO. 10, 2312–2319
http://dx.doi.org/10.3109/13880209.2016.1155629
D
ow
nl
oa
de
d 
by
 [
U
N
IC
A
M
P]
 a
t 1
2:
50
 1
4 
Se
pt
em
be
r 
20
17
 
medicine to treat pain and inflammation (Araujo-Neto et al.
2010). However, other parts of this plant seem to have an unex-
plored potential against oral microorganisms of clinical relevance,
such as streptococci and yeasts.
S. cumini, commonly known as jambolan, is a large evergreen
and foliaceous tree whose seeds, bark, fruit and leaves have been
used in traditional medicine. It is reported to have antioxidant,
antinociceptive, hypoglycemic, anti-Leishmania and antimicrobial
properties (Eshwarappa et al. 2014; Quintans et al. 2014;
Rodrigues et al. 2015).
Interestingly, the antifungal properties of S. obtusifolium and S.
cumini have never been comprehensively studied despite their use
in folk medicine as antimicrobial (Albuquerque et al. 2011), which
could open avenues for discovery of novel bioactive molecules
and drug development and also aggregate value to the ethnophar-
macological knowledge of the communities living in the Caatinga
biome (28 million people as of 2013, according to the Brazilian
Institute of Geography and Statistics - IBGE).
In this pioneering study, the antifungal activity of extracts
and/or fractions from the leaves of S. obtusifolium and S.
cumini from the Caatinga biome was determined on planktonic
cells of C. albicans. Their effects on biofilm morphology and
viability and mode of action were further established. With the
perspective of future clinical use, the cytotoxic effects of these
extracts were investigated upon murine and human cells.
Further scientific exploration of these species could provide
new opportunities for the development of needed novel antifun-
gals to manage oral candidiasis.
Materials and methods
Plant material
Sideroxylon obtusifolium and Syzygium cumini leaves were col-
lected in April and August 2013, respectively, in the semi-arid
region in the countryside area of Campina Grande, Paraıba State,
Brazil (7 220 2500 S, 35 590 3200 W), under permission of the
Brazilian Ministry of Environment (Council for the
Administration and Management of Genetic Patrimony - CGEN)
via the National Council for Scientific and Technological
Development (CNPq) [010637/2014-1]. Botanical specimens were
identified by Prof. Maria Regina de Vasconcellos Barbosa, curator
of Lauro Pires Xavier Herbarium (http://inct.florabrasil.net/partici-
pantes/herbarios-curadores/jpb/) at the Department of Molecular
Biology, Federal University of Paraıba, Jo~ao Pessoa, Paraıba, under
voucher numbers JPB 57.985 and JPB 58.543, respectively.
After cleaning processing, the leaves were dried in an air-circu-
lating oven at 40 C until stabilization of final weight, and then
ground in a Wiley mill (SL 30 Solab, Piracicaba, SP, Brazil).
Hydroalcoholic extracts of the leaves were prepared by maceration
following the proportion 200 g of ground plant to 1 L of 70%
hydroalcoholic solution. The extracts were subjected to evaporation
under reduced pressure, lyophilized at 20 to 40 C and stored
in glass containers, protected from light and under refrigeration.
Extract fractionation
S. obtusifolium extract was subjected to liquid–liquid fractionation
(Cunha et al. 2013) using organic solvents in order of increasing
polarity: hexane, dichloromethane, ethyl acetate and n-butanol
(Nb). The final portion corresponded to the aqueous phase. Our
preliminary experiments (not shown) indicated that the dichloro-
methane and Nb fractions had the best antimicrobial activity and
therefore were selected for further testing.
Phytochemical analysis
The extract(s)/fraction(s) with the best activity were quantified for
their content of total polyphenols, total flavonoids, condensed tan-
nins and saponins. The method described by Chandra and Mejıa
(2004) was used to determine the content of total polyphenols in
equivalent milligrams of gallic acid, with absorbance reading at
757 nm. The content of total flavonoids, expressed in equivalent
milligrams of quercetin, was determined according to Meda et al.
(2005) with absorbance reading at 420 nm. The content of con-
densed tannins, expressed as milligrams of catechin equivalents,
was quantified using the method proposed by Makkar and Becker
(1993) with absorbance reading at 500 nm. Finally, the content of
saponins in milligrams of diosgenin was determined according to
Makkar et al. (2007) with absorbance reading at 544 nm.
Microorganism and growth conditions
In all microbiological assays a reference strain of Candida albicans
ATCC 10231, obtained from the American Type Culture
Collection, was used. Cultures were kept in a glycerol stock solu-
tion at 80 C and grown in Sabouraud dextrose broth and agar
(HIMEDIA Laboratories Pvt. Ltd., Mumbai, India) at 35 C for
24 h in aerobic atmosphere.
Inhibitory and lethal effects of the plant extracts on C.
albicans cells
This study investigated the antifungal susceptibility of C. albicans
to the action of S. obtusifolium extract and fractions and S. cumini
extract (Sc). Their minimum inhibitory concentration (MIC) was
established using 96-well U-bottom tissue culture microplates.
Fresh solutions of the extracts and fractions were prepared using
10% (v/v) ethanol as vehicle. Then, aliquots of 100 lL of the sam-
ples were used to perform serial dilutions in RPMI-1640 medium
with 0.165 M MOPS (Sigma-Aldrich, St. Louis, MO). Nystatin,
caspofungin diacetate (Sigma-Aldrich, St. Louis, MO) and ampho-
tericin B (Uni~ao Quımica Farmacêutica Nacional, SP, Brazil) were
used as positive controls, and the vehicle as the negative control.
Sterility of the culture medium and samples and culture viability
were also monitored. Fungal inoculum was adjusted at 530 nm to
2.5 103 CFU/mL in the wells totaling a volume of 200 lL. Plates
were incubated at 35 C for 24 h. The MIC was defined as the
lowest concentration of the sample that inhibited visible microbial
growth (CLSI 2002).
The lethal effects of the samples were determined through
their minimum fungicidal concentrations (MFC) by subculturing
on Sabouraud dextrose agar plates an aliquot from each well
having a concentration equal to or higher than the MIC. The
plates were incubated at 35 C for 48 h. The MFC was defined
as the lowest concentration of the extract or bioactive fraction
that showed no visible growth on the agar plate (Manohar
et al. 2001).
Finally, the MFC/MIC ratio was calculated to determine if the
extracts and their bioactive fractions have fungistatic (MFC/
MIC 4) or fungicidal (MFC/MIC< 4) properties (Siddiqui et al.
2013).
Antifungal mode of action
These assays aimed to elucidate the antifungal mechanisms
through which the extracts and bioactive fractions interact with
the fungal cells. Two major mechanisms were investigated: direct
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interaction with the cell wall biosynthesis (sorbitol assay) or mem-
brane ionic permeability (ergosterol assay).
Effects on cell wall biosynthesis
The MIC of the extracts or bioactive fractions was determined in
the presence of an osmotic protector through an adaptation of the
microdilution technique proposed by the CLSI (2002). Culture
medium (RPMI-1640) was added to each well of the microplate
and serial dilutions of the samples and controls were carried out.
Finally, 100 lL of inoculum (2.5 105 CFU/mL) prepared with
RPMI-1640 supplemented with 0.8 M sorbitol (final concentra-
tion) (Sigma-Aldrich, St. Louis, MO) was transferred to the wells.
Caspofungin diacetate (Sigma-Aldrich, St. Louis, MO) was used as
positive control. Yeast growth, media sterility and inertness of
vehicle (negative control) were also monitored. Plates were incu-
bated at 35 C and read after 2 and 7 d (Lima et al. 2013; Freires
et al. 2014).
Effects on membrane permeability
The MIC of the extracts or bioactive fractions was determined in
absence and presence of exogenous ergosterol (Sigma-Aldrich, St.
Louis, MO) at concentrations of 100, 200 and 400 lg/mL through
an adaptation of the microdilution technique (CLSI 2002).
Amphotericin B, which highly binds to ergosterol, was used as
positive control. Yeast viability in presence of different concentra-
tions of ergosterol and of vehicle was checked as a negative con-
trol. Plates were read after 24 h of incubation at 35 C (Lima et al.
2013; Freires et al. 2014).
Scanning electron microscopy (SEM)
Biofilm cultures (2.5 105 CFU/mL) were grown in chambered
glass slides (BD FalconTM, Bedford, MA) containing RPMI-1640
and were treated with the extract/bioactive fraction at different
concentrations (MIC, MFC, 5 x MIC and 10 x MIC) or with
nystatin (MIC). The chambered slides were kept shaking at
100 rpm, 35 C for 72 h to form consistent biofilms. After that,
the samples were washed twice to remove planktonic cells and
kept in a 3% glutaraldehyde solution (pH 7.4) for 12 h at room
temperature, followed by serial dehydration with ethanol (50, 70
and 90%) for 10 min and drying for 45 min under laminar flow.
At last, the chambers were separated from the slides and the latter
were coated with a gold pellicle in a metallizer device to be
observed under scanning electron microscopy (Jeon JSM 5600LV
microscope, Tokyo, Japan) (Freires et al. 2014).
Confocal laser scanning microscopy (CLSM)
C. albicans cultures were started in yeast nitrogen base (YNB)
medium (HimediaVR , Mumbai, India) supplemented with 50 mM
glucose for 24 h at 35 C. Cells were harvested (1200 rpm, 10 min,
10 C), washed twice, resuspended in PBS (0.15 M, pH 7.2, Ca2þ-
and Mg2-free) and adjusted to 5 106 CFU/mL (530 nm,
k¼ 0.08–0.1). Final inocula concentration in the wells was
2.5 105 CFU/mL. For preparation of C. albicans biofilms, glass
slides (324 mm2 surface area) were immersed in 12-well flat-bot-
tom plates (TPP, Trasadingen, Switzerland) containing fetal
bovine serum (FBS) (Vitrocell Embriolife, Campinas, SP, Brazil),
followed by incubation for 24 h at 35 C. Then the slides were
washed with PBS to remove residual FBS and transferred to new
plates containing the C. albicans suspension, followed by incuba-
tion for 90 min at 35 C. Subsequently, the slides were gently
washed to ensure the removal of non-adhered cells before immer-
sion in YNB medium containing the extract/bioactive fraction,
vehicle and nystatin. The plates were incubated at 35 C for 48 h
for biofilm formation (adapted from Kuhn et al. 2002; Freires
et al. 2015). 72 h biofilm formation was not possible using this
method as the biofilm pellicle on the slide turns to be thick and
detaches from the surface after 48 h.
For the CLSM analysis, the biofilms were placed in wells con-
taining 10 lM FUN-1 (F-7030, Life Technologies, Carlsbad, CA)
and 25 lg/mL Concanavalin A, Alexa FluorVR 488 Conjugate
(C11252, Life Technologies, Carlsbad, CA) in 3 mL of PBS. The
plates were then incubated for 45 min at 35 C and the slides
were subsequently visualized on a Leica TCS-SP5 confocal micro-
scope (Mannheim, Germany) equipped with an HCX-PL-APO
63x oil immersion objective lens. Each biofilm sample was
scanned at five randomly selected points and representative
images were selected. 2D images were generated and processed
using LAS X Suite for WindowsVR .
Cytotoxic activity on murine and human cell cultures
Murine macrophage RAW264.7 were grown in RPMI medium and
human keratinocyte HaCat were cultured in DMEM medium, both
supplemented with 10% fetal bovine serum (Gibco BR,
Gaithersburg, MD). A viability assay was carried out in which
RAW264.7 and HaCat cells were seeded onto 96-well plates at a
density of 1 105 and 1 104 cells/well, respectively, and allowed
to adhere for 30 h. After that, the adhered cells were exposed to the
extracts/bioactive fraction at the concentrations of 200, 100, 20 and
10 lg/mL in dimethyl sulfoxide (DMSO)/medium and vehicle con-
trol. Final DMSO concentration (1%) did not affect cell viability.
After 24 h of incubation, viability was determined by the addition
of 200 lL of MTT solution (0.3 mg/mL). The precipitated formazan
crystals were solubilized in ethanol, and the absorbance was deter-
mined at 570 nm using a microplate reader (Mosmann 1983).
Statistical analysis
All the tests in this study were carried out in triplicate in three
independent experiments. Descriptive and inferential statistics
were used to analyse the data on GraphPad Prism version 5.0
(GraphPad Software, San Diego, CA). One-way analysis of vari-
ance followed by Tukey-Kramer post-test was used to analyse the
intra- and inter-group differences in the cytotoxicity assays, with
type I error set as 0.05.
Results
Extracts and fractions yields
The extracts and fractions yields, expressed in relation to dry
weight of plant material (%, w/w) were as follows: S. obtusifolium
extract (3.64%) – dichloromethane fraction (13.1% in relation to
crude extract)/ Nb fraction (11.8%, in relation to crude extract) –
and Sc (6.25%).
Phytochemical analysis
The extract and/or fraction with the best antifungal activity were
chemically characterized. Table 1 shows the phytochemical
2314 J. V. PEREIRA ET AL.
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makers of the Nb fraction from S. obtusifolium extract and Sc.
The results showed a predominance of total flavonoids in the Nb
fraction and saponins in the Sc.
Antifungal activity and mode of action
The inhibitory and lethal concentrations of the extracts, bioactive
fractions and standard drugs against C. albicans can be found in
Table 2. The Nb fraction from S. obtusifolium hydroalcoholic
extract was shown to concentrate the most active constituents of
S. obtusifolium with MIC/MFC values lower than those of the
crude extract and dichloromethane fraction. Therefore, the Nb
fraction was selected to be further tested as to mode of action,
effects on biofilm morphology and viability and cytotoxicity. The
crude extract of S. cumini was also tested in this study, which was
also proven to have considerable antifungal activity against plank-
tonic C. albicans cells.
Considering the promising antifungal effects of the Nb fraction
and Sc, we next studied their modes of action upon yeast cells.
The findings showed that Nb fraction and Sc do not interfere
with cell wall biosynthesis pathways as does Caspofungin (used as
a control), because the antifungal susceptibility of yeasts to them
was unaltered either in the presence or absence of an osmotic
protector (Table 3). Instead, their MIC values increased between 4
and 16 times with the addition of exogenous ergosterol, which
indicates that they seem to complex with membrane ergosterol
and this could potentially lead to increased membrane ionic per-
meability, cell leakage and death (Table 4).
Effects on biofilm morphology and viability
SEM analysis was initially carried out to evaluate the effects of the
extract and bioactive fraction on the morphology and integrity of
C. albicans biofilms.
We observed that the Nb fraction from S. obtusifolium severely
affected the biofilm cell structures even at low inhibitory concen-
trations (62.5 lg/mL), and that at higher concentrations the dam-
ages were lethal to the cells. Marked structural changes with
membrane rupture and possible leakage of cellular contents were
observed. Therefore, the Nb fraction was shown to exert antifun-
gal effects on C. albicans biofilms (Figure 1).
Similarly, Sc also affected C. albicans biofilm cells, with dele-
terious effects at concentrations as low as the MIC (125 lg/mL)
and evident destruction from 500 lg/mL (MFC). Nystatin, used as
positive control, was effective in disrupting biofilm integrity; and
the vehicle did not affect the cells (Figure 2).
The inhibitory effects of the Nb fraction and Sc on the viability
of C. albicans biofilms were visualized by CLSM (Figure 3).
Viability of fungal cells upon the action of the tested substances
could be observed through Concanavalin A (Alexa FluorVR 488
conjugate) and FUNV
R
1 cell staining. Both the fraction and the
extract affected the viability of the biofilm cells when compared to
the vehicle.
Cytotoxic activity
Cytotoxicity assays were carried out to provide preliminary
evidence on whether these antifungal agents would affect or not
host cells in a future clinical setting. Figure 4 shows that Sc
did not show toxicity on murine macrophage cells, with no sig-
nificant difference at any tested concentration (10–200 lg/mL)
when compared to the vehicle. However, the Nb fraction from
S. obtusifolium extract showed toxicity on macrophages at concen-
trations close to its MIC/MFC. On human keratinocytes, the tox-
icity threshold (limitrophe concentration that does not affect cell
viability) for Sc and Nb fraction from S. obtusifolium extract was
found to be 100 and 20 lg/mL, respectively, again lower than
their MIC/MFC values.
Discussion
This study describes the antifungal potential and mode of action
of S. obtusifolium and S. cumini against C. albicans. The plant
material was collected in a semi-arid biome in northeastern Brazil
termed ‘Caatinga’. It is a unique biogeographic region and consid-
ered one of the largest intermittently dry tropical forests in
America (Penninghton et al. 2009). This biodiverse ecological set-
ting is a shelter for 4 478 native plants species (Siqueira-Filho
et al. 2012), including S. obtusifolium and exotic species, such as
S. cumini, which are mostly explored by the local communities in
folk medicine and for commercial purposes.
Due to the presence of major compounds in the leaves of
S. obtusifolium and S. cumini that are known to have antifungal
activity, such as total flavonoids (Onsare & Arora 2014; Yixi et al.
2015) and saponins (Sparg et al. 2004; Coleman et al. 2010),
respectively, and in view of the potential sustainability of their use
Table 1. Phytochemical markers of the Nb fraction from Sideroxylon obtusifolium hydroalcoholic extract and Syzygium cumini hydroalcoholic extract.
Group Condensed tannins Total flavonoids Saponins Polyphenolsa
S. obtusifolium, Nb fraction 5.5 6 0.98 39.11 6 6.62 – *
Sc 54.26 6 0.39 23.04 6 3.02 820.35 6 225.38 100.10 6 39.97
Content values are expressed as mean 6 SD (mg/g). (–) not detected; (*) not analysed.
aNote that the column ‘polyphenols’ refers to a general measurement of all polyphenolic compounds in the sample, including, for instance, flavonoids. In this case, the
same compound might have been quantified in both ‘total flavonoids’ and ‘polyphenols’ analyses.
Table 2. Antifungal activity of Sideroxylon obtusifolium extract and its fractions,
Syzygium cumini extract, and standard drugs on Candida albicans ATCC 10231
(values are expressed as lg/mL).
Group MIC MFC MFC/MIC ratioa
S. obtusifolium
Crude extract 1000 >1000 >1
Dichloromethane fraction 1000 1000 1
Nb fraction 62.5 250 4
S. cumini
Crude extract 125 500 4
Monodrugs
Nystatin 0.97 1.95 2
Amphotericin B 0.07 0.14 2
Caspofungin 0.48 0.97 2
aDetermines a fungistatic (MFC/MIC 4) or fungicidal (MFC/MIC< 4) activity.
Table 3. Effects of the Nb fraction from Sideroxylon obtusifolium extract, and Sc
on Candida albicans (ATCC 10231) cell wall biosynthesis (sorbitol assay). Values
are expressed as lg/mL.
Group Without sorbitol With sorbitol
S. obtusifolium, Nb fraction from extract 250 250
Sc 500 500
Caspofungin 0.97 62.5
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Table 4. Effect of different concentrations of exogenous ergosterol (100–400 lg/mL) on the antifungal activity of the Nb fraction from Sideroxylon obtusifolium extract;
Syzygium cumini extract; and Amphotericin B on Candida albicans ATCC10231.
Group MIC in the absence of ergosterol
MIC in the presence of different concentrations of ergosterol
100 lg/mL 200 lg/mL 400 lg/mL
S. obtusifolium, Nb fraction from extract 62.5 500 500 500
Sc 125 500 1000 2000
Amphotericin B 0.07 4.88 9.76 19.53
Yeast growth in presence of ergosterol þ þ þ þ
Vehicle þ þ þ þ
þ, fungal growth.
Figure 1. Effects of the Nb fraction from Sideroxylon obtusifolium extract on biofilm morphology/integrity. SEM photomicrographs (5000x) showing Candida albicans bio-
film cells treated with different concentrations of the Nb fraction (A) 62.5 lg/mL (MIC), (B) 250 lg/mL (MFC), (C) 312.5 lg/mL (5xMIC), (D) 625 lg/mL (10xMIC); as well as
(E) 0.97 lg/mL nystatin and (F) vehicle. The Nb fraction affected cell structures even at low concentrations (MIC). Nystatin was used as positive control, and the vehicle
did not affect the biofilm cells.
Figure 2. Effects of the Syzygium cumini extract on biofilm morphology/integrity. SEM photomicrographs (5000x) showing Candida albicans biofilm cells treated with dif-
ferent concentrations of Sc: (A) 125 lg/mL (MIC), (B) 500 lg/mL (MFC), (C) 625 lg/mL (5xMIC), (D) 1250 lg/mL (10xMIC); as well as (E) 0.97 lg/mL nystatin and
(F) vehicle. It can be noted that Sc affected cell structures at concentrations as low as 125 lg/mL. Nystatin was used as positive control, and the vehicle did not affect
the biofilm cells.
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for therapeutic purposes, this study was carried out to elucidate
the antifungal mode of action of these species and their effects
upon yeast cell morphology and viability in biofilm cultures.
In agreement with other studies, the extract of S. obtusifolium
showed weak antifungal activity (Cruz et al. 2007; Almeida et al.
2012), as well as its dichloromethane fraction. However, its Nb
fraction showed better activity (lower MIC/MFC values) than the
crude extract, indicating that the fractionation scheme adopted in
this study (Jeon et al. 2011) was successful. Likely, the predomin-
ance of flavonoids in the Nb fraction may have favored its anti-
Candida properties. Flavonoids extracted from different plant spe-
cies were found to have strong inhibitory effects on the formation
and metabolic activity of C. albicans biofilms or planktonic cells
(Onsare & Arora 2014), which means that this phytochemical
class could be a marker for antifungal activity.
The crude extract of S. cumini was also tested in this study,
which showed fungistatic activity. Other studies in the literature
have reported on the antifungal effects of S. cumini on C. albicans
(Oliveira et al. 2007; H€ofling et al. 2010; Santos et al. 2012), but
have not further described its mode of action and effects on bio-
film morphology and viability (see further in the discussion). As
to the chemical profile, the major compounds found in the extract
of the leaves in this study were saponins. Coleman et al. (2010)
found that two saponin family members disrupted C. albicans
hyphae and biofilm formation; thus, it is assumed that saponins
are possibly the active compounds in the Sc.
The next step in this bioprospection study was to elucidate the
mode of action of the fraction or extract with the best antimicro-
bial activity determined by MIC/MFC. Herein, two possible chief
mechanisms were investigated for Nb and Sc antifungal effects on
yeasts: (i) disrupting cell wall biosynthesis or (ii) increasing mem-
brane ionic permeability (Freires et al. 2014). The findings showed
that both the Nb fraction from S. obtusifolium extract and Sc con-
sistently bind to membrane ergosterol, leading to increased cell
membrane permeability due to the formation of pores in the
membrane. When at higher concentrations (250–500 lg/mL), their
effects on the yeast cells are lethal, because ergosterol is crucial to
maintain cell integrity, viability and normal growth (Ghannoum
& Rice 1999). It is worth noting that other cell targets might also
be involved in the antifungal activity of Nb fraction and Sc, war-
ranting further investigation. In this study, the plant extract/frac-
tion were found to be fungistatic (MFC/MIC¼ 4) and
amphotericin B, fungicidal (MFC/MIC¼ 2), although both
showed similar modes of action. This could be explained by other
aspects that play a role in the major properties of antifungal
drugs, such as drug affinity to ergosterol and chemical stability of
Figure 3. Effects on biofilm viability. This is a representative 2-D confocal imaging of Candida albicans biofilms treated with (A) Nb fraction from S. obtusifolium extract
(5xMIC: 312.5 lg/mL); (B) S. cumini hydroalcoholic extract (5xMIC: 625 lg/mL); (C) Nystatin (MIC: 0.97 lg/mL) [positive control]; and (D) Vehicle (negative control). The
structures depicted in green (Concanavalin A, Alexa FluorVR 488 Conjugate) represent the yeast cell wall, and those depicted in yellow (FUNVR 1 Cell Stain) are nonviable
cells, metabolically inactive. The viable cells, in turn, convert the dye FUN-1 to red fluorescent aggregates (63x optical magnitude, 2.85 zoomed-in). Concanavalin A select-
ively binds to polysaccharides, including alpha-mannopyranosyl and alpha-gluco-pyranosyl residues, and gives a green fluorescence. FUN-1 is a fluorescent dye taken up
by yeast cells; in the presence of metabolic viability it is converted from a diffuse yellow cytoplasmic stain to red. It can be noted that both Sc and Nb fraction affected
the viability of C. albicans cells when compared to the vehicle.
Figure 4. Cytotoxicity of Sc and Nb fraction from S. obtusifolium extract on murine macrophage cells (A) and human keratinocytes (B). Each concentration marked with
‘*’ differs significantly from the vehicle (p< 0.05, One-way ANOVA followed by Tukey-Kramer).
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the molecules determining the biological effects (Milhaud et al.
2002).
The study of the antimicrobial properties of natural products
should prioritize biofilm growth models, in order to provide greater
reliability of data and closer approach to clinically relevant condi-
tions (Freires et al. 2014). In this study, scanning electron and con-
focal laser microscopy were used to visualize C. albicans biofilms
grown on abiotic surfaces and treated with the Nb bioactive frac-
tion and Sc. It was found that both products disrupted the struc-
ture and viability of biofilm cells. The association between biofilm
formation and antimicrobial resistance remains to be a serious
health issue in the current days (Sim~oes 2011), which encourages
the search for active molecules able to disrupt biofilm integrity.
Hence, the harmful effects of the extract/fraction upon biofilm
assembly seen in this study could contribute to render the biofilm
more susceptible to other antifungal drugs. In addition to oral can-
didiasis, this result may also be useful for studies addressing yeast
biofilm formation on the surfaces of medical devices, such as cen-
tral venous catheters and endotracheal tubes. Further studies
should also perform a quantitative analysis of the effects of the
extract and fraction on the biofilm composition (e.g., estimation of
extracellular polysaccharides and other components of the biofilm
matrix), biovolume (e.g., number of cells vs. exposure time, biofilm
inhibitory concentration) and viability (e.g., XTT assay).
Following validation of antifungal activity, the experimental
samples were finally checked for their cytotoxic activity on mur-
ine and human cell cultures, in order to provide evidence for
future clinical use. Overall, cytotoxic activity was detected on both
cell lines, particularly the Nb fraction, as the cytotoxicity values
found were lower than those of the MIC/MFC of the extract/frac-
tion. As expected, Sc showed a less cytotoxic profile when com-
pared to the Nb fraction, given that the fractionation process may
concentrate toxic compounds in the bioactive fractions.
Nevertheless, it is a preliminary cell-based assay with 24 h expos-
ure of cells to the test substances, which would be rather different
from the clinical use. Ribeiro et al. (2014) reported that S. cumini
hexanic extract has low toxicity on murine macrophages, with
IC50 of 31.64 lg/mL. There have been no reports on the toxicity
of S. obtusifolium in vitro.
An in vivo study by Ruela et al. (2011) evaluated the acute tox-
icity in mice of the ethyl acetate fraction from the stem bark of S.
obtusifolium. The authors found that such fraction, rich in poly-
phenols, has very low cytotoxicity with LD50 of 777 mg/kg by
intraperitoneal route. With regard to S. cumini, an in vivo study
by Silva et al. (2012) showed that the hydroalcoholic extract of S.
cumini leaves did not exert acute or chronic toxic effects on
rodents by oral route, with LD50 of 489 mg/kg. More sophisticated
toxicological assays are now encouraged to further determine
whether the Nb fraction and Sc would pose a risk or not against
the host cells.
The clinical management of oral candidiasis in most patients
includes the administration of topical or systemic antifungal drugs
as well as disinfection of dentures in patients presenting denture-
related atrophic stomatitis (Gendreau & Loewy 2011). Hence, the
Nb fraction and Sc may be of interest in both approaches, with
particular focus on the denture disinfection protocol due to their
potential toxicity toward host cells. In addition, several studies
have also suggested the combination of synthetic drugs with nat-
ural products in order to improve the efficacy of both drugs and
manage toxicity upon clinical use (Hemaiswaryaa et al. 2008;
Castro et al. 2015).
Taken altogether, the findings of this bioprospection study
support the view that these plant materials warrant further
exploration of their biological properties and toxicity in future
non-clinical studies and clinical trials. In summary, the Nb frac-
tion from S. obtusifolium extract, and Sc, which are species from
the unique Caatinga biome, showed antifungal activity against C.
albicans biofilm, probably due to the predominance of flavonoids
and saponins, respectively, in their chemical composition. Their
ability to bind to ergosterol and thus increase cell membrane per-
meability may explain the deleterious effects observed on biofilm
morphology and viability. The Nb fraction and Sc showed relative
cytotoxic effects on murine and human cells. Other toxicological
assays and in vivo studies of efficacy are now encouraged to fur-
ther investigate the antifungal activity of the Nb fraction from S.
obtusifolium and Sc as alternative candidates for the treatment of
oral candidiasis.
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tas vasculares das Caatingas do rio S~ao Francisco [The fall of the myth:
composition, richness and conservation of vascular plants of Caatingas by
the S~ao Francisco River]. In: Siqueira-Filho JA. A flora das Caatingas do rio
S~ao Francisco: historia natural e conservaç~ao, Andrea Jakobsson, Rio de
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